Skip to main content
. 2014 Jun 28;3(5):1313–1321. doi: 10.1002/cam4.278

Figure 2.

Figure 2

Freedom from biochemical failure for the three patient groups, according to the treatment type (A–C) and in the subgroup with intermediate risk (>15% and ≤30%) (D).